Find similar content

Source channel @githubtrending · Post #14923 · Jul 7

#rust#ai_agent#developer_tools#enterprise#fine_tuning#on_prem#open_source#rag#self_hosted#swe_bench#vscode Refact.ai is a free, open-source AI software development agent that helps you code faster and smarter by deeply understanding your code and integrating with tools like GitHub, databases, Docker, and debuggers. It offers unlimited, context-aware code auto-completion, can generate, refactor, explain, debug code, and create tests and documentation across 25+ programming languages. You can run it securely on your own servers, use top AI models like GPT-4o, and connect your own API keys. This means you save time on repetitive tasks, improve code quality, and collaborate better, making your development workflow much more efficient and productive[1][3][5]. https://github.com/smallcloudai/refact

Hashtags

#rust #ai_agent #developer_tools #enterprise #fine_tuning #on_prem #open_source #rag #self_hosted #swe_bench #vscode

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment